Swiss pharma lags behind in global innovation ranking
An employee works on the production of the Pfizer-BioNTech COVID-19 vaccine at a factory in Marburg, Germany, on January 20, 2021.
Keystone / Biontech Se Handout
Pharmaceutical companies are currently among the most innovative firms in the world alongside tech and software giants such as Apple and Alphabet, according to the Boston Consulting Group (BCG). But Swiss pharma companies rank low in their latest Top 50 list.
This content was published on
2 minutes
Keystone-SDA/swissinfo/sb
Español
es
La farmacéutica suiza se rezaga en ranking de innovación
“Pharma companies performed strongly this year, joining technology and software companies that have dominated the rankings in recent years,” said BCG in a statementExternal link on Thursday. The group have released their “Most Innovative Companies 2021” report that features a Top 50 ranking.
In 2021, nine pharmaceutical companies were ranked by BCG experts among the 50 most innovative companies, three times more than the previous year.
US pharmaceutical companies Pfizer and Johnson & Johnson, which have developed vaccines against Covid-19, were ranked the 10th and 20th most innovative firms. Abbott Labs (29th) and Merck & Co (35th) also featured highly in the table that was topped by Apple, Alphabet, Amazon, Microsoft and Tesla.
Swiss pharmaceutical giants Novartis and Roche, which did not launch any Covid vaccines, were ranked 36th and 48th most innovative firms, respectively. They were nonetheless ahead of the British-Swedish multinational AstraZeneca (49th) and the German firm Bayer (50th).
More
More
The Swiss Connection Podcast: Hear Swiss science stories for the world
Why is Switzerland so sweet on cryptocurrency? What’s it like to be a Swiss expat in America? Swiss women couldn’t vote until when?!
While not at the forefront in developing vaccines, Swiss companies have been stepping up their involvement in manufacturing Covid-19 vaccines. Lonza is producing ingredients for the Moderna vaccine at its production plant in Visp, southern Switzerland, while pharma giant Novartis has signed deals to help manufacture both the Pfizer/BioNtech and CureVac vaccines. Roche has been focusing on Covid-19 tests and treatments.
The question of whether Switzerland should have developed its own Covid vaccines has been in the headlines in recent weeks. Swiss Health Minister Alain Berset has been caught up in a controversy for reportedly turning down an offer by Lonza to produce vaccines domestically.
Newspapers have claimed that in spring 2020 Berset missed the chance to secure a Swiss-based vaccine production line via Lonza. Berset has since said there was no clear connection between investing in Lonza and securing access to the Moderna vaccine.
A parliamentary commission plans to investigate the matter. It’s not known when their findings will be published.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Swiss parliament wants to expand support for asbestos victims
This content was published on
The expansion of financial support for asbestos victims by the Swiss National Accident Insurance Fund has cleared its first parliamentary hurdle.
Extra month of Swiss pension can be paid out from end of 2026
This content was published on
The 13th monthly pension payment can be paid out from December 2026. However, it has not yet been decided how it will be financed.
Addictions cause billions in damage in Switzerland
This content was published on
The alcohol, tobacco and gambling industries generate billions in revenue. At the same time, they cost the economy billions, according to Addiction Switzerland.
Swiss parliament moves closer to partial ban of tobacco ads
This content was published on
Tobacco advertising should be partially banned in the print media. On Monday the House of Representatives gave the go-ahead for restrictions on advertising, with some relaxations.
Online platforms and UBS in sights of Swiss price watchdog
This content was published on
With over 800 cases processed, including just under 400 recommendations, 2024 once again ended with a record number of cases for the Swiss price watchdog.
Swiss federal office sees no reason to end deportations of asylum-seekers to Croatia
This content was published on
Switzerland's State Secretariat for Migration (SEM) continues to deport asylum-seekers to Croatia. It thus rejects a demand from the Swiss Refugee Council in mid-February, which called for a halt to the returns.
ChatGPT responds to negative emotions and therapy, research shows
This content was published on
Stressful information can also cause anxiety in artificial intelligence (AI). As scientists in Zurich have shown, it's even possible to calm the GPT-4 AI model with mindfulness exercises.
Mortgage benchmark fall paves way for potential rent cuts in Switzerland
This content was published on
Switzerland’s national benchmark for mortgage costs dropped to the level it had before the global inflation surge, paving the way for potential rent reductions.
Switzerland in race for sufficient Covid immunisation
This content was published on
Health authorities have called for an extra effort from the Swiss population to keep Covid infections as low as possible in the next few months.
Switzerland mulls future European coordination on medical supplies
This content was published on
“The pandemic has shown us that we are very dependent, maybe too much so, on other markets,” Swiss President Guy Parmelin has said.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.